PPARβ/δ could be targeted by a specific agonist in skeletalmuscle in order to prevent metabolic disorders such as insulin resistance andobesity by increasing catabolism of lipid in muscle and decreasing lipidaccumulation in adipose tissue. The gene discussed is PPARD; the disease is Insulin resistance.